1. Home
  2. COCP vs BFRG Comparison

COCP vs BFRG Comparison

Compare COCP & BFRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • BFRG
  • Stock Information
  • Founded
  • COCP 2006
  • BFRG 2017
  • Country
  • COCP United States
  • BFRG United States
  • Employees
  • COCP N/A
  • BFRG N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • BFRG Retail: Computer Software & Peripheral Equipment
  • Sector
  • COCP Health Care
  • BFRG Technology
  • Exchange
  • COCP Nasdaq
  • BFRG Nasdaq
  • Market Cap
  • COCP 15.4M
  • BFRG 16.4M
  • IPO Year
  • COCP N/A
  • BFRG 2023
  • Fundamental
  • Price
  • COCP $1.22
  • BFRG $1.50
  • Analyst Decision
  • COCP Strong Buy
  • BFRG
  • Analyst Count
  • COCP 1
  • BFRG 0
  • Target Price
  • COCP $6.00
  • BFRG N/A
  • AVG Volume (30 Days)
  • COCP 4.6M
  • BFRG 139.3K
  • Earning Date
  • COCP 11-12-2025
  • BFRG 11-07-2025
  • Dividend Yield
  • COCP N/A
  • BFRG N/A
  • EPS Growth
  • COCP N/A
  • BFRG N/A
  • EPS
  • COCP N/A
  • BFRG N/A
  • Revenue
  • COCP N/A
  • BFRG $33,257.00
  • Revenue This Year
  • COCP N/A
  • BFRG N/A
  • Revenue Next Year
  • COCP N/A
  • BFRG N/A
  • P/E Ratio
  • COCP N/A
  • BFRG N/A
  • Revenue Growth
  • COCP N/A
  • BFRG N/A
  • 52 Week Low
  • COCP $1.12
  • BFRG $1.09
  • 52 Week High
  • COCP $3.26
  • BFRG $4.84
  • Technical
  • Relative Strength Index (RSI)
  • COCP 37.81
  • BFRG 59.51
  • Support Level
  • COCP $1.17
  • BFRG $1.32
  • Resistance Level
  • COCP $1.31
  • BFRG $1.54
  • Average True Range (ATR)
  • COCP 0.09
  • BFRG 0.11
  • MACD
  • COCP -0.00
  • BFRG 0.01
  • Stochastic Oscillator
  • COCP 20.00
  • BFRG 80.77

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About BFRG Bullfrog AI Holdings Inc.

Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.

Share on Social Networks: